Medeligo

Medeligo™ provides fast, easy access to oncology literature and information on-the-go. Using proprietary technology, Medeligo™ searches the most trusted sources in real-time to find the latest and most relevant information available in seconds.

FINGERTIP ACCESS TO THE LATEST ONCOLOGY INFORMATION

Benefits
• Find and read the latest oncology literature in seconds
• Watch relevant videos and access images
• Prepare for patient rounds, consults, and surgeries
• Answer patient-specific questions quickly at tumor boards
• Share, print, or save articles

Limited introductory price of $49.99 (Reg. $149.99) for the All Access (1 year) subscription — includes a risk-free 3-month trial.

To learn more, please visit http://medeligo.com.

After the free trial period, your subscription will continue for $49.99/year, and your iTunes account will be charged. If you do not wish to continue your subscription after your free trial ends, turn off auto-renew in your Account Settings 24 hours prior to the end of your free trial.
Subscriptions will automatically renew when they expire unless you turn off auto-renew at least 24-hours before the end of your subscription period. Your account will be charged $49.99 for renewal within 24-hours prior to the end of your subscription period. You can manage your subscription and turn off auto-renew by going to your Account Settings.
Any unused portion of a free trial period, if offered, will be forfeited when the user purchases a subscription to that publication, where applicable.

You can read more about our terms and conditions here:
Privacy policy: http://medeligo.com/privacy-policy/
Terms of service: http://medeligo.com/terms-of-service/